Better Treatments. Real Relief.
At Relevium, our diverse team shares one mission: developing superior treatments for those living with painful disorders.
OUR JOURNEY
Why We Exist
At Relevium, we believe those suffering from persistent, debilitating pain deserve safer, longer-lasting, targeted solutions.
Our Values
BREAKTHROUGH
Patient-first mindset -
we prioritise the needs and well-being of people living with chronic pain.
Scientific integrity - rigorous research, transparent development, and safety-driven innovation.
Innovation & adaptability - building a flexible platform that can evolve to meet diverse therapeutic needs.
Transparency & collaboration - working with healthcare professionals, researchers, and stakeholders to move forward ethically and effectively.
Relevium Medical's leadership has direct experience advancing TRPV1-targeted, capsaicin-based analgesics and has worked across every stage of drug development - from CMC and clinical development to regulatory approval and commercialisation.
This experience was built at leading pharmaceutical companies, including Roche, Sanofi, GlaxoSmithKline, Actelion, and BioMarin.
Our Team
WHO WE ARE
Clinical Advisory Board
WHO WE ARE
Our Clinical Advisory Board is led by three of the world's foremost authorities in pain and musculoskeletal medicine: Dr Nathaniel Katz, Harvard-trained neurologist and pain-trial pioneer who chaired the FDA's own analgesics advisory committee; Professor David Hunter, ranked the world's leading osteoarthritis expert and Editor-in-Chief of Osteoarthritis and Cartilage; and Professor Philip Conaghan, a globally recognised OA authority who chaired NICE's Osteoarthritis Clinical Guidance Committee and has served as Chief Investigator on multiple pivotal osteoarthritis trials.
Together, they've shaped how the world diagnoses, treats, and studies chronic pain and joint disease - from FDA policy to NICE guidelines to hundreds of peer-reviewed publications.
Relevium Medical is further supported by a network of clinical advisors across pain medicine, orthopaedics, and musculoskeletal care, bringing frontline clinical perspective to the company's development strategy.
Our Supporters and Funders
WHO WE ARE
